Quarterly ResultJul 29, 2026, 04:12 PM
Teladoc Health Q2 Revenue $606.9M, down 4%; Net Loss $38.9M
AI Summary
Teladoc Health reported mixed financial results for Q2 2026, with revenue decreasing 4% year-over-year to $606.9 million and a net loss of $38.9 million. Adjusted EBITDA also saw a 5% decline to $65.7 million. The Integrated Care segment showed growth with revenue up 1% and a healthy adjusted EBITDA margin, while the BetterHelp segment experienced a significant 12% revenue decline due to accelerated pressure on cash pay revenue. The company provided a full-year 2026 revenue outlook of $2,362 million to $2,447 million and adjusted EBITDA of $271 million to $303 million, reflecting ongoing challenges in BetterHelp but strategic actions to scale insurance offerings.
Key Highlights
- Q2 2026 revenue decreased 4% year-over-year to $606.9 million.
- Q2 2026 net loss was $38.9 million, or $0.21 per share.
- Q2 2026 adjusted EBITDA decreased 5% year-over-year to $65.7 million.
- Integrated Care segment revenue grew 1% to $394.3 million, with 16.5% adjusted EBITDA margin.
- BetterHelp segment revenue declined 12% to $212.6 million, with 0.2% adjusted EBITDA margin.
- Full Year 2026 revenue expected between $2,362 million and $2,447 million.
- Full Year 2026 adjusted EBITDA projected at $271 million to $303 million.
- Q2 2026 free cash flow was $35.7 million, down from $61.2 million.
Price Impact
More from TDOC